Computational Modeling of Protein Networks Predicts Treatment Outcomes in Multiple Myeloma (MM)

Background: MM is a highly refractory disease that is rarely cured. While introduction of novel therapies has improved survival and overall response rates (ORR), complete remission (CR) rates remain low (30%) and relapse is still frequent. 

Blood Journal 2017